{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:32:28Z","timestamp":1760851948931},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1054\/plef.2000.0160","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T11:33:28Z","timestamp":1032435208000},"page":"311-317","source":"Crossref","is-referenced-by-count":23,"title":["Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function"],"prefix":"10.1054","volume":"62","author":[{"given":"J.M.","family":"Dogn\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Neven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Delarge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Massereel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/plef.2000.0160_RF1","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2000.0160_RF2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/261558a0","article-title":"Identification of an enzyme in platelet microsomes which generates thromboxane A2from prostaglandin endoperoxides","volume":"261","author":"Needleman","year":"1976","journal-title":"Nature"},{"key":"10.1054\/plef.2000.0160_RF3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1126\/science.959827","article-title":"Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2","volume":"193","author":"Ellis","year":"1976","journal-title":"Science"},{"key":"10.1054\/plef.2000.0160_RF4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.158.2.393","article-title":"Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures","volume":"158","author":"Pawlowski","year":"1983","journal-title":"J Exp Med"},{"key":"10.1054\/plef.2000.0160_RF5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0049-3848(83)90256-6","article-title":"Increased synthesis of thromboxane B2and 6-keto-PGF1alphain hand veins from patients with deep venous thrombosis","volume":"32","author":"Saldeen","year":"1983","journal-title":"Thromb Res"},{"key":"10.1054\/plef.2000.0160_RF6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1054\/plef.2000.0160_RF7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-8703(93)90001-P","article-title":"Increased production of thromboxane A2 by coronary arteries after thrombolysis","volume":"125","author":"Saldeen","year":"1993","journal-title":"Am Heart J"},{"key":"10.1054\/plef.2000.0160_RF8","first-page":"15","article-title":"Thromboxane A2: biosynthesis and effects on platelets","volume":"10","author":"Granstr\u00f6m","year":"1982","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1054\/plef.2000.0160_RF9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.71.2.345","article-title":"Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation","volume":"71","author":"Hamberg","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2000.0160_RF10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.1981.tb16814.x","article-title":"Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2and thromboxane A2on some isolated smooth muscle preparations","volume":"73","author":"Coleman","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2000.0160_RF11","first-page":"435","article-title":"Pharmacological actions of SQ-29548, a novel selective thromboxane antagonist","volume":"234","author":"Ogletree","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2000.0160_RF12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(84)92328-6","article-title":"BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man","volume":"1","author":"Gresele","year":"1984","journal-title":"Lancet"},{"key":"10.1054\/plef.2000.0160_RF13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0952-3278(92)90227-A","article-title":"A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery","volume":"45","author":"Uchida","year":"1992","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1054\/plef.2000.0160_RF14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1211\/0022357991772998","article-title":"Thromboxane A2receptor antagonism in man and in rat by a sulfonylcyanoguanidine (BM-144) and a sulfonylurea (BM-500)","volume":"51","author":"Masereel","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1054\/plef.2000.0160_RF15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0223-5234(94)90145-7","article-title":"Synthesis and pharmacology of pyrid-3-ylsulfonylureas and thioureas as astrocytic Na+ K+ 2Cl- cotransporter inhibitors","volume":"29","author":"Masereel","year":"1994","journal-title":"Eur J Med Chem"},{"key":"10.1054\/plef.2000.0160_RF16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0223-5234(96)88244-4","article-title":"Synthesis and pharmacology of pyrid-3-ylsulfonylcyanoguanidinines as diuretics","volume":"30","author":"Masereel","year":"1995","journal-title":"Eur J Med Chem"},{"key":"10.1054\/plef.2000.0160_RF17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1021\/ed073p1185","article-title":"Use of infrared spectroscopy in monitoring a new method for the preparation of sulotroban, an antithrombotic drug","volume":"73","author":"Nuhrich","year":"1996","journal-title":"J Chem Educ"},{"key":"10.1054\/plef.2000.0160_RF18","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1021\/jm00047a016","article-title":"Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition; [2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids","volume":"37","author":"Cozzi","year":"1994","journal-title":"J Med Chem"},{"key":"10.1054\/plef.2000.0160_RF19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","article-title":"The aggregation of blood platelets","volume":"168","author":"Born","year":"1963","journal-title":"J Physiol"},{"key":"10.1054\/plef.2000.0160_RF20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0032-1313612","article-title":"Description of an in vitro platelet function anayzer-PFA-100","volume":"21","author":"Kundu","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/plef.2000.0160_RF21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/jm00059a005","article-title":"Modeling of human thromboxane A2receptor and analysis of the receptor-ligand interaction","volume":"36","author":"Yamamoto","year":"1993","journal-title":"J Med Chem"},{"key":"10.1054\/plef.2000.0160_RF22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.1990.tb15812.x","article-title":"Glibenclamide is a competitive antagonist of the thromboxane A2receptor in dog coronary artery in vitro","volume":"100","author":"Cocks","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2000.0160_RF23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-2999(97)01458-1","article-title":"Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein","volume":"341","author":"Stanke","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2000.0160_RF24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1021\/jm9707941","article-title":"Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors","volume":"42","author":"Soyka","year":"1999","journal-title":"J Med Chem"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327800901601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327800901601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T15:53:42Z","timestamp":1554998022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327800901601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0952327800901601"],"URL":"https:\/\/doi.org\/10.1054\/plef.2000.0160","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}